A1C Results Explained: Diabetes Ranges, Treatment Goals, and How to Track Changes Over Time
A1Cdiabetesblood testsglucose managementpatient education

A1C Results Explained: Diabetes Ranges, Treatment Goals, and How to Track Changes Over Time

CClinical News Editorial Team
2026-11-18
5 min read

Understand A1C ranges, estimated average glucose, individualized targets, test limitations, and when to repeat testing.

An A1C test offers a longer view of average blood glucose than a single finger-stick reading. This guide explains A1C results, commonly used diabetes ranges, estimated average glucose, individualized treatment goals, factors that can make the result misleading, and a practical way to track changes over time. Use it to prepare for a conversation with a qualified clinician—not to diagnose or change treatment on your own.

Overview

A1C, also called hemoglobin A1C or HbA1c, estimates the proportion of hemoglobin in red blood cells that has glucose attached to it. Because red blood cells usually circulate for several months, the result reflects an approximate average rather than the glucose level at one specific moment. Recent weeks may influence the result more than earlier months.

The commonly used interpretation for nonpregnant adults is:

A1C resultCommon interpretation
Below 5.7%Usually considered in the normal range
5.7% to 6.4%Usually considered the prediabetes range
6.5% or higherIn the diabetes range; diagnosis generally requires confirmation unless symptoms and other findings make the diagnosis clear

These cutoffs are screening and diagnostic reference points, not a complete assessment of health. A clinician may repeat the test or use a different glucose test, particularly when the result does not fit symptoms, home readings, or medical history. Pregnancy, childhood, anemia, kidney disease, and conditions affecting red blood cells can require different approaches.

For many nonpregnant adults who have diabetes, a treatment goal near or below 7% is commonly used as a starting point. The right goal is individualized. It may be higher or lower depending on factors such as age, duration of diabetes, risk of hypoglycemia, other illnesses, pregnancy status, treatment burden, and personal preferences. A target is a clinical decision, not a grade or a measure of effort.

How to estimate

A1C can be translated into estimated average glucose, or eAG, to make the result easier to compare with glucose-meter readings. A commonly used approximation in mg/dL is:

eAG (mg/dL) = 28.7 × A1C − 46.7

For mmol/L, an approximate conversion is:

eAG (mmol/L) = 1.59 × A1C − 2.59

Examples include:

A1CApproximate eAG
5.7%117 mg/dL (6.5 mmol/L)
6.5%140 mg/dL (7.8 mmol/L)
7.0%154 mg/dL (8.6 mmol/L)
8.0%183 mg/dL (10.2 mmol/L)
9.0%212 mg/dL (11.8 mmol/L)

eAG is an average, not a daily target and not a prediction of every reading. Two people with the same A1C may have very different patterns, including high readings after meals, overnight lows, or wide swings. Continuous glucose monitors and meters can show those patterns, but their readings should be interpreted alongside the A1C and the device’s limitations.

Inputs and assumptions

To interpret an A1C responsibly, record more than the percentage. The following inputs can change its meaning:

  • Why the test was ordered: screening, confirming a new diagnosis, monitoring established diabetes, or evaluating a treatment change.
  • Timing: note the test date and the dates of medication, diet, activity, illness, or weight changes. A1C does not respond instantly to a change.
  • Glucose data: bring meter or continuous-monitor summaries when available, especially if they do not match the A1C.
  • Medicines and adherence: record prescribed diabetes medicines, steroids, supplements, missed doses, and recent dose changes. Never alter a dose solely from this article.
  • Health conditions: tell the clinician about anemia, recent bleeding or transfusion, kidney or liver disease, pregnancy, dialysis, or a hemoglobin variant. These may affect accuracy or require another test.
  • Symptoms and safety: thirst, frequent urination, unexplained weight loss, vomiting, confusion, or symptoms of low blood glucose require clinical attention rather than waiting for the next A1C.

Hemoglobin variants and some laboratory methods can interfere with A1C measurement. If a result changes unexpectedly or conflicts with glucose readings, ask whether the laboratory method is suitable and whether an alternative such as fasting glucose, an oral glucose tolerance test, or another marker is appropriate.

Worked examples

Example 1: A screening result of 6.0%. This falls in the commonly used prediabetes range. It does not by itself establish diabetes. The next step may be confirmation, a review of risk factors, and a prevention plan tailored to the person. A future result should be compared with the date, intervening changes, and any relevant glucose measurements.

Example 2: A result of 7.0% in a person with established diabetes. The number is near a frequently used general treatment goal, but it cannot determine whether the current plan is appropriate. The clinician may also review glucose lows, post-meal readings, kidney function, medicines, and treatment burden. A person having repeated lows may need a different plan even if the A1C appears favorable.

Example 3: A result rises from 7.1% to 8.0%. Using the approximation above, eAG changes from about 157 mg/dL to 183 mg/dL. This comparison is useful but incomplete. Ask about missed medicines, access problems, infection, steroid treatment, reduced activity, stress, diet changes, or a test result that may be unreliable. A clinician can decide whether treatment, monitoring, or repeat testing is needed.

A simple tracking table can make follow-up more productive:

DateA1CeAGMedicines or changesIllness or other contextQuestions
YYYY-MM-DD%mg/dL or mmol/L

When to recalculate

Revisit your interpretation after each A1C test, a meaningful medication change, a new diagnosis, pregnancy, a prolonged illness, or a major change in eating pattern, activity, weight, or access to care. An A1C usually needs time to reflect a sustained change, so testing too soon can make the result difficult to interpret. Many care plans use testing about twice a year when treatment is stable and more often—often around every three months—when goals are not being met or treatment has changed. The appropriate interval depends on the individual plan.

Recalculate the eAG whenever the A1C changes, but treat the result as an estimate. Update this reference before relying on it if professional guidance changes, diagnostic thresholds are revised, or laboratory and hemoglobin-variant information changes. A review at least annually is sensible for patient education resources.

Before your next appointment, write down the A1C date, the result, your current target, recent glucose patterns, medicine changes, and any low-glucose episodes. Ask: “What target applies to me?”, “Does this result match my glucose readings?”, “When should I repeat the test?”, and “Could another condition be affecting the measurement?” Seek urgent medical advice for severe symptoms, very high or very low glucose readings, persistent vomiting, dehydration, or confusion.

Related Topics

#A1C#diabetes#blood tests#glucose management#patient education
C

Clinical News Editorial Team

Medical Resources Editor

Senior editor and content strategist. Writing about technology, design, and the future of digital media. Follow along for deep dives into the industry's moving parts.